Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-15-040949
Filing Date
2015-07-02
Accepted
2015-07-02 21:04:24
Documents
1
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v414797_4.html 4  
1 OWNERSHIP DOCUMENT v414797_4.xml 4 3531
  Complete submission text file 0001144204-15-040949.txt   5195
Mailing Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170 212-584-4171
Caladrius Biosciences, Inc. (Issuer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8090 Services-Misc Health & Allied Services, NEC

Mailing Address 13 FOX MEADOW RD SCARSDALE NY 10583
Business Address
LOSORDO DOUGLAS W (Reporting) CIK: 0001583810 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33650 | Film No.: 15971876